Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011641
Filing Date
2024-08-08
Accepted
2024-08-08 17:10:32
Documents
87
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20240630x10q.htm   iXBRL 10-Q 2820916
2 EX-10.1 iova-20240630xex10d1.htm EX-10.1 120037
3 EX-10.2 iova-20240630xex10d2.htm EX-10.2 179039
4 EX-31.1 iova-20240630xex31d1.htm EX-31.1 12338
5 EX-31.2 iova-20240630xex31d2.htm EX-31.2 12225
6 EX-32.1 iova-20240630xex32d1.htm EX-32.1 7100
7 EX-32.2 iova-20240630xex32d2.htm EX-32.2 7165
  Complete submission text file 0001558370-24-011641.txt   11032851

Data Files

Seq Description Document Type Size
8 EX-101.SCH iova-20240630.xsd EX-101.SCH 65300
9 EX-101.CAL iova-20240630_cal.xml EX-101.CAL 61607
10 EX-101.DEF iova-20240630_def.xml EX-101.DEF 292074
11 EX-101.LAB iova-20240630_lab.xml EX-101.LAB 496467
12 EX-101.PRE iova-20240630_pre.xml EX-101.PRE 441028
90 EXTRACTED XBRL INSTANCE DOCUMENT iova-20240630x10q_htm.xml XML 1921452
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 241189582
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)